11th European AIDS Conference / EACS
Webcasted Presentation

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!

Gerd Fatkenheuer
Germany  
Efficacy and Safety of Maraviroc (MVC) Plus Optimized Background Therapy (OBT) in Viraemic, Antiretroviral Treatment-Experienced Patients Infected with CCR5-Tropic (R5) HIV-1 in Europe, Australia and North America (MOTIVATE 2): 48-Week Results
English
2007-10-25
 
16 slide(s)
Extra Features Available
Advisory boards and lecture grants fees from: Abbott, BI, BMS, GSK, Tibotec, Gilead, Pfizer, Schering, Monogram